LeMaitre Vascular, Inc. (LMAT) Stock Score, Valuation & Financial Research
LeMaitre Vascular, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 53/100.
Quick answer for LMAT
LeMaitre Vascular, Inc. currently has a Wall Street Score of 53/100. The stored market price is $80.24. Its financial score is 46/100. Its valuation score is 43/100. These figures are a research snapshot, not a buy or sell recommendation.
What LeMaitre Vascular, Inc. does
Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely c
LMAT financial snapshot
- Wall Street Score:
- 53/100
- Current price:
- $80.24
- Market capitalization:
- $1.83B
- Revenue:
- $256.3M
- Net income:
- $62.4M
- Free cash flow:
- $74.5M
- Cash:
- $26.9M
- Total debt:
- $189.8M
- EPS:
- 2.55
- P/E ratio:
- 31.5x
- Financial score:
- 46/100
- Valuation score:
- 43/100
- Revenue score:
- 27/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $74.5M, showing positive cash generation.
- The balance sheet shows $26.9M of cash versus $189.8M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 43/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 46/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research LMAT
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.